<DOC>
	<DOCNO>NCT01041105</DOCNO>
	<brief_summary>The goal study describe clinical presentation , indication , operative treatment well assess morbidity , mortality , overall performance revisional Roux-en-Y gastric bypass ( RYGB ) either fail functional antireflux surgery `` ARS '' obese patient . With information , hope determine feature might assist u advance knowledge Gastro-Esophageal Reflux Disease `` GERD '' , best option primary ARS , mechanisms failure obese population well identify predictor outcome revisional surgery population .</brief_summary>
	<brief_title>Gastric Bypass After Previous Anti-reflux Surgery</brief_title>
	<detailed_description>The epidemic overweight obesity United States America along comorbidities continue expand . Bariatric surgery demonstrate effective sustained method control severe obesity comorbidities . For instance , type 2 diabetes mellitus completely resolve 76.8 percent , systemic arterial hypertension resolve 61.7 percent , dyslipidemia improve 70 percent , obstructive sleep apnea-hypopnea syndrome resolve 85.7 percent . Furthermore , bariatric surgery significantly increase life expectancy ( 89 percent ) decrease overall mortality ( 30-40 percent ) , particularly deaths diabetes , heart disease , cancer . Lastly , preliminary evidence downstream saving associate bariatric surgery offset initial cost 2 4 year . Since 1998 , substantially progressive increase bariatric surgery . In 2005 , American Society Metabolic Bariatric Surgery `` ASMBS '' report 81 percent bariatric procedure approach laparoscopically . 205,000 people , 2007 , bariatric surgery United States approximately 80 percent Gastric Bypass . Moreover , mismatch eligibility receipt bariatric surgery le 1 percent eligible population treat morbid obesity bariatric surgery . Along increase number elective primary weight loss procedure , 20 percent post RYGB patient sustain weight loss beyond 2 3 year primary bariatric procedure . Thus , revisional surgery poor weight loss re-operations technical mechanical complication rise parallel manner . Three systematic review meta-analysis examine association obesity ( BMI &gt; 30kg/m2 ) several GERD-related disorder , include 1 ) GERD symptom , 2 ) erosive esophagitis `` EE '' , 3 ) esophageal adenocarcinoma `` EA '' . Obesity associate 1.5-to-2-fold increased risk GERD symptom EE 2- 2.5-fold increase risk EA . In two large case-control study , abdominal diameter ( waist-hip ratio ) , BMI , independent risk factor another GERD-related disorder , Barrett´s esophagus `` BE '' . Current pathophysiological mechanism GERD obese encompass follow . 1 ) Mechanical : I ) increase intra-gastric pressure : increase intra-peritoneal abdominal wall fat mass increase intra-abdominal peri-gastric pressure subsequent increase gastroesophageal pressure gradient `` GEPE '' augment esophageal acid exposure . Each BMI unit increase correspond 10 percent increase intra-gastric pressure . II ) Hiatal Hernia : `` HH '' disrupt integrity sphincter mechanisms prolongs esophageal acid clearance . Thin , normal , overweight , obese subject 1.0 , 1.9 , 2.5 , 4.2 risk HH compare thin subject , respectively . 2 ) Motility : I ) Increased Transient LES Relaxation `` TLESR '' associate acid reflux postprandial period , especially inspiration . II ) Low LES basal pressure : Increased prevalence abnormally low LES basal pressure overweight obese comparison normoweight subject . III ) Esophageal motility abnormality : Jaffin et al , esophageal manometry , report 61 percent patient alter esophageal motility 59 percent alter visceral pain perception ( asymptomatic ) . IV ) Delayed gastric emptying : mostly associate one major comorbidities , diabetes mellitus . 3 ) Esophageal sensitivity : Mercer et al. , Bernstein test , find significant difference normoweight obese subject without clinical evidence GERD ( 0 percent vs. 86 percent , respectively ) esophageal hypersensitivity . 4 ) Hormonal : mostly mediate estrogen adiponectin . 5 ) Environmental ( Diet ) : high-fat , saturated fatty acid , high-cholesterol , high caloric density diet associate high likelihood perceive acid reflux event ; fat may confer sensory effect activate pain facilitatory pathway deactivate pain inhibitory pathway . The recent data conclusive whether increase BMI affect acid-suppressive therapy GERD . However , MacDougall et al . find increase BMI significantly associate long-term acid suppression therapy . This explain base either high prevalence factor predispose overweight obese subject severe GERD , HH , great GEPG , increase number TLESR , standard dos PPI´s suboptimal patient increase BMI GERD . Broad indication antireflux surgery include : 1 ) Reflux food associate HH , 2 ) despite successful medical treatment poor moderate symptom control optimize PPI therapy , patient opts surgery , 3 ) Complicated GERD without include severe dysplasia . Available traditional ARS either 1 ) fundoplication , commonly perform procedure partial -Toupet , Dor- complete -Nissen- , procedure limit use 2 ) Hill operation , 3 ) pyloroplasty , 4 ) vagotomy antrectomy , 5 ) duodenal switch . Long-term control typical symptom primary laparoscopic Nissen fundoplication `` LNF '' , properly select patient experienced surgical team , attain 90 percent patient confirm LNF gold standard treatment severe GERD . In cohort study 166 patient follow 11 year , Smith et al find preoperative response acid-reducing medication , typical symptom , BMI &lt; 35 Kg/m2 predict successful outcome . However , HH size , normal 24-hour pH score , age &gt; 50 year , female gender , prior abdominal surgery previous study find associated poor outcome corroborate study . Other risk factor failure short esophagus , HH great 3 cm , diaphragmatic stressor retch , sport weight lift , high-speed motor vehicle accident among others . Another study find increase BMI predictor poor outcome . Perez et al , retrospective cohort analysis 224 patient undergoing LNF transthoracic ARS , find significantly increase recurrence rate GERD obese overweight compare normoweight patient , regardless procedure type . In contrast , cohort study 257 consecutive patient undergo LNF , D´Alessio et al analyze outcome base BMI ( &lt; 25 , 25-30 , &gt; 30 kg/m2 ) ; No significant difference symptom score clinical success rate find among different subset . However , mean BMI obese patient 33 kg/m2 ( obesity class I ) three patient &gt; 35 kg/m2 . Regardless contradictory data LNF efficacy obesity , several study show effectiveness RYGB GERD morbidly obese patient symptom , endoscopic finding , manometry pH-metry result , endoscopic biopsy-histopathology . There four retrospective cohort study assess mostly early outcome convert ARS RYGB . First , Sarr et al analyze 19 patient underwent open conversion RYGB . Next , Ikramuddin et al described anatomic finding fundoplication failure laparoscopic conversion RYGB 11 patient . Lastly , seven patient , Raftopoulos et al Donnelly et al report feasibility high morbidity rate well . In summary , little information best primary ARS best revisional strategy address intractable severe reflux fail fundoplication obese population . Also , lack data best revisional procedure address obesity patient status post functional competent ARS . With pilot retrospective study , advance knowledge along exist literature , draw preliminary clinical recommendation .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Status post , either open laparoscopic , primary Nissen fundoplication follow requirement : Met NIH criterion bariatric surgery With functional fail antireflux surgery ( Nissen fundoplication ) Laparoscopic approach revisional surgery Any type revisional bariatric procedure Nonstandard revisional RYGB surgery Open approach revision surgery Missing record and/or unreachable patient scant information analysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>Nissen funduplication</keyword>
	<keyword>Antireflux surgery</keyword>
	<keyword>Revisional Gastric Bypass</keyword>
	<keyword>Re-operative bariatric surgery</keyword>
	<keyword>Bariatric surgery</keyword>
	<keyword>Nissen</keyword>
	<keyword>Conversion Nissen Gastric Bypass</keyword>
</DOC>